Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFE trial for prevention of anthracycline-related cardiotoxicity in non-metastatic breast cancer
2015-000914-23Phase 3Terminated
- Sponsor
- Università degli Studi di Firenze
- Start
- Nov 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of bisoprolol and ramipril in Anthracycline Cardiomyopathy (2 arms), sponsored by Università degli Studi di Firenze. Primary endpoint: Subclinical cardiac damage. Started Nov 2020; status: terminated.
02
Drugs
bisoprololramipril
03
Conditions
Anthracycline Cardiomyopathy
Beyond the preview
Go deeper on 2015-000914-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000914-23.